Alvotech (ALVO) Preferred Stock Liabilities (2021)
Alvotech's (ALVO) quarterly Preferred Stock Liabilities came in at $250.0 million in Q4 2021.
Alvotech (ALVO) Preferred Stock Liabilities (2021) Analysis & Trends
Alvotech (ALVO) has 1 years of Preferred Stock Liabilities data on file, last reported at $250.0 million in Q4 2021.
- Quarterly Preferred Stock Liabilities changed N/A year-over-year to $250.0 million in Q4 2021, while the trailing twelve-month figure through Dec 2021 was $250.0 million (changed N/A YoY) and the FY2021 annual result came in at $250.0 million, changed N/A from the prior year.
- Preferred Stock Liabilities held at $250.0 million in Q4 2021.
- In the past five years, Preferred Stock Liabilities ranged from a high of $250.0 million in Q4 2021 to a low of $250.0 million in Q4 2021.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Preferred Stock Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.51 Bn | 43.55 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.52 Bn | 39.86 Bn | 2.15 Bn | - |
| 3 | Zoetis | 32.43 Bn | 30.75 Bn | 1.05 Bn | - |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn | - |
| 5 | United Therapeutics | 21.87 Bn | 19.21 Bn | 683.80 Mn | - |
| 6 | Viatris | 18.98 Bn | 18.09 Bn | 1.46 Bn | - |
| 7 | Neurocrine Biosciences | 15.43 Bn | 15.04 Bn | 935.80 Mn | - |
| 8 | Elanco Animal Health | 12.02 Bn | 11.49 Bn | 798.00 Mn | - |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - | - |
| 10 | Alvotech | 1.30 Bn | 1.30 Bn | 5.09 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2021 | 250.00 Mn |